Simplified Papilla Preservation Flap(SPPF) and Enamel Matrix Derivative(EMD) With or Without Connective Tissue(CTG) Wall for the Treatment of Non Contained Infrabony Defects. A Randomized Controlled Clinical Trail

NCT ID: NCT06530199

Last Updated: 2024-07-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-07-31

Study Completion Date

2025-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Research is to compare and evaluate the clinical and radiographic outcomes of the enamel matrix derivative with or without connective tissue wall graft for noncontained infrabony defects using simplified papilla preservation technique .

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Research is to compare and evaluate the clinical and radiographic outcomes of the enamel matrix derivative with or without connective tissue wall graft for noncontained infrabony defects using simplified papilla preservation technique .The objectives is to assess the probing pocket depth reduction, clinical attachment level gain,gingival recession depth and radiographic bone gain. The TEST group will be treated withSIMPLIFIED PAPILLA PRESERVATION flap with connective tissue graft and enamel matrix derivative and the CONTROL group will be treated with SIMPLIFIED APILLA PRESERVATION flap and enamel matrix derivative. The total number of participants included will be 30 (Control-15; Study-15) with a 6 month follow up.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Intrabony Periodontal Defect

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

control group

Simplified papilla preservation flap with enamel matrix derivative will be performed

Group Type ACTIVE_COMPARATOR

Enamel matrix derivative

Intervention Type PROCEDURE

connective tissue graft and Enamel matrix derivative in the defect area

Test group

Simplified papilla preservation flap with connective tissue graft and enamel matrix derivative will be performed

Group Type EXPERIMENTAL

Enamel matrix derivative

Intervention Type PROCEDURE

connective tissue graft and Enamel matrix derivative in the defect area

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Enamel matrix derivative

connective tissue graft and Enamel matrix derivative in the defect area

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Connective tissue graft technique

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients willing to participate in the study.
* Participants aged ≥18 years to 55 years.
* Presented with non contained infra bony defects.
* Presence of at least 1 non contained infra bony defect(IBD) with a pocket probing depth ≥6mm after reevaluation of the hygienic phase and a depth of IBD ≥3mm as detected on radiographs, with radiographic angulation of ≥37⸰ , and exhibiting a 1 or 2 wall infra bony defect15(assessed by a bone sounding and confirmed intrasurgically)
* Patient's full mouth plaque score and bleeding score \<20% at the time of surgical procedure.
* No history of periodontal surgery at the experimental site.

Exclusion Criteria

* Grade III mobility, endodontically treated teeth.
* Pregnant and lactating females.
* History of tobacco smoking .
* Patients with systemic disease.
* Known allergy or hypersensitivity to EMD.
* Presence of pulpal and peri apical involvement
Minimum Eligible Age

18 Years

Maximum Eligible Age

55 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Krishnadevaraya College of Dental Sciences & Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Prabhuji MLV, MDS

Role: CONTACT

Phone: 9448057407

Email: [email protected]

Head of the department and professor

Role: CONTACT

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

02_D012_147502

Identifier Type: -

Identifier Source: org_study_id